Loading...
NPI 1205361052 · Bedford, NH · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Minimally Invasive Surgery Center Of N.e., LLC is a ambulatory surgical clinic/center provider located in Bedford, New Hampshire. This profile covers 14 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Minimally Invasive Surgery Center Of N.e., LLC |
| Address | 4 Hawthorne Dr |
| City | Bedford |
| State | NH |
| ZIP | 03110 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | April 28, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.1M |
| Medicaid | $169.5K |
MINIMALLY INVASIVE SURGERY CENTER OF N.E., LLC is operating as an Ambulatory Surgical Clinic/Center with a clear spine- and pain-management focus: its Medicare top codes are 63685 (neurostimulator pulse generator placement), 22869 (interspinous device insertion), and 63650 (epidural electrode placement), and it also bills heavily for image-guided epidural and facet injections across both payers. The mix of high-reimbursement implant codes and very high-volume injection codes indicates the facility combines lower-cost, high-throughput pain injections with more specialized outpatient implant surgeries.
Medicare revenue is concentrated: the precomputed top 3 Medicare codes account for 62.3% of the provider's total Medicare revenue, led by 63685 at 29.0% ($605.4K), 22869 at 20.4% ($427K), and 63650 at 12.9% ($270.4K). This concentration shows that a majority of the $2.1M in Medicare receipts flows from a small set of spine-implant and stimulation procedures.
Medicaid revenue is effectively limited to injection and epidural services: the top 3 Medicaid codes account for 100.0% of Medicaid revenue, with 64483 responsible for 68.7% ($116.2K) and 62323 for 31.3% ($52.9K). With total Medicaid revenue of $169.5K, the provider’s Medicaid billing footprint is narrowly focused on image-guided spinal injections and represents a much smaller scale relative to Medicare.
Payer mix is heavily Medicare-weighted: Total Medicare revenue is $2.1M versus Total Medicaid revenue of $169.5K, indicating the center is predominantly supported by Medicare payments rather than Medicaid. The disparity in scale suggests strategic and operational emphasis on Medicare beneficiaries and procedures that attract higher per-claim payments.
The provider shows exceptional competitive standing nationally for at least one high-revenue procedure: 22869 ranks #1 of 72 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), signaling national-level dominance in interspinous device placements. In addition, multiple injection codes (64493 at the 99th percentile; 64483 and 62323 at the 98th percentile) are reported at notably above-typical national volumes, underscoring a regional/national strength in both implantation and injection-based spine care.
Within the New Hampshire Medicaid market the provider is a leading source for these injection services: 64483 ranks #1 of 4 in-state (100th percentile; typical, unremarkable volume) and 62323 ranks #1 of 9 in-state (100th percentile; notably above typical state volume). High Medicaid claim counts for those codes (830 claims for 64483 and 448 claims for 62323) indicate the center is a major in-state operator for outpatient spinal injections on Medicaid.
Operational profile implied by claim counts and code mix: high claim volumes for injection codes on Medicare (e.g., 64483: 535 claims, 64493: 404 claims, 62323: 376 claims) combined with fewer, high-reimbursement implant procedures (e.g., 63685: 34 claims at $17805 avg paid/claim) suggest a dual-mode business model—high-throughput image-guided pain management services cross-subsidizing episodic, higher-resource implant surgeries. This pattern is consistent with an ambulatory surgical center that runs frequent outpatient injection clinics alongside scheduled implant operations.
The provider has an established NPI tenure that supports these patterns: NPI enumerated 2017-04-28 (~9 years ago), indicating the center has been operating long enough to develop specialty volume and state-level market position in spine injections and implants. The combination of tenure, concentrated Medicare revenue, and in-state Medicaid leadership for injections suggests a mature specialty outpatient practice rather than a new or transient billing profile.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 63685 | The provider inserts or replaces a spinal neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that requires a connection… | 30 | $17,810 | $605.4K |
| 22869 | Through a minimally invasive approach, the provider inserts an interlaminar stabilization or interspinous distraction, or decompression, device (IPD) and attaches it to the bony projections (spinous… | 50 | $8,370 | $427K |
| 63650 | In this procedure, the provider places electrodes in the epidural space to relieve pain and reduce or eliminate spasms. | 70 | $3,760 | $270.4K |
| 63655 | In this procedure, the provider removes a portion of the vertebra called the lamina and places a permanent plate/paddle electrode in the epidural space, or area between the dura membrane and the wall… | 20 | $13,730 | $233.5K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 540 | $300 | $158.4K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 400 | $270 | $107.5K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 380 | $250 | $94K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 150 | $530 | $79.8K |
| 63047 | The provider performs a laminectomy (excision of the thin bony plate at the back of a vertebra), facetectomy (excision of an area of a vertebra characterized by its smooth surface), and foraminotomy… | 10 | $2,310 | $30K |
| 64479 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either cervical or thoracic). | 80 | $320 | $26.1K |
Showing 1–10 of 14
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
14 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 63685 | 1 | 10 | 30 | $10,520 | $304.9K |
| 22869 | 1 | 10 | 40 | $5,870 | $217.4K |
| 63655 | 1 | 10 | 20 | $7,200 | $122.4K |
| 63650 | 1 | 10 | 30 | $2,670 | $104.1K |
| 64635 | 1 | 40 | 40 | $370 | $16.1K |
| 64483 | 2 | 40 | 60 | $180 | $15.4K |
| 62323 | 1 | 50 | 80 | $150 | $13.8K |
| 63047 | 13 | 20 | 10 | $730 | $13.8K |
| 64493 | 1 | 50 | 60 | $170 | $12.6K |
| 64479 | 1 | 10 | 50 | $200 | $9.2K |
Showing 1–10 of 14
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 830 | $140 | $116.2K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 450 | $120 | $52.9K |
How this provider's Medicaid billing volume and revenue compare to other New Hampshire providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Hampshire median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 1 | 10 | 160 | $190 | $54.8K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 1 | 10 | 20 | $140 | $14.4K |
Other providers in the same ZIP code as Minimally Invasive Surgery Center Of N.e., LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.